Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
Case Western Reserve Scientists Discover Novel Molecular Target for Parkinson’s Disease
Researchers at Case Western Reserve University have discovered a new biochemical pathway that could lead to treatments targeting the underlying causes of Parkinson’s disease....
Sanofi Received Breakthrough Therapy and Orphan Drug Designations for Rilzabrutinib
Sanofi has announced that Rilzabrutinib has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the treatment of warm autoimmune hemolytic anemia (wAIHA)....
Immix Biopharma’s NXC-201 Secures FDA Breakthrough Therapy Status for AL Amyloidosis
Immix Biopharma, Inc. has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration for its investigational therapy, NXC-201, aimed at treating relapsed or refractory AL amyloidosis....
Ipsen’s IPN60340 receives FDA Breakthrough Therapy Designation for first-line unfit AML
Ipsen has announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation (BTD) to IPN60340 in combination with venetoclax and azacitidine...
Protara Therapeutics Secures FDA Breakthrough Therapy Designation for TARA-002 in Pediatric Lymphatic Malformations
Protara Therapeutics, Inc., has received both Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration (FDA) for TARA-002....
FDA Grants Breakthrough Therapy Designation to Revolution Medicine’s Zoldonrasib
Revolution Medicines, Inc., has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to its experimental drug zoldonrasib....
Praxis Precision Medicines Secures FDA Breakthrough Therapy Designation for Ulixacaltamide
Praxis Precision Medicines, Inc. has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for ulixacaltamide hydrochloride for the treatment of essential tremor....
FDA Grants Breakthrough Therapy Status to Incyte’s First-in-Class mutCALR Antibody
Incyte has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to INCA033989, a first-in-class monoclonal antibody targeting mutant calreticulin (mutCALR)....
Ionis Receives FDA Breakthrough Therapy Designation for Zilganersen in Alexander Disease
Ionis Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to zilganersen for the treatment of Alexander disease (AxD), a rare, progressive and often fatal neurological condition....
Celltrion Secures FDA Approval for OMLYCLO® 300 mg, First Interchangeable Biosimilar to XOLAIR
Celltrion has announced U.S. FDA approval of a new 300 mg/2 mL prefilled syringe presentation of OMLYCLO® (omalizumab-igec), the first and only biosimilar designated as interchangeable with XOLAIR® (omalizumab)....
